nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bioassay for platelet activating factor which uses washed rabbit platelets and the specific antagonist web 2086: Methodological considerations and its application to human tissue samples
|
Heuer, H. |
|
1988 |
35 |
5 |
p. 837- 1 p. |
artikel |
2 |
Acceleration of healing in an animal model of inflammatory bowel disease by BN52021
|
Wallace, J.L. |
|
1988 |
35 |
5 |
p. 813- 1 p. |
artikel |
3 |
Activity of a novel anti-thrombotic compound, PCA-4230, on PAF-acether effects
|
Ortega, M.P. |
|
1988 |
35 |
5 |
p. 826- 1 p. |
artikel |
4 |
Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease
|
Satoh, Kei |
|
1988 |
35 |
5 |
p. 685-698 14 p. |
artikel |
5 |
Activity of the new and specific PAF-antagonists WEB 2170 and STY 2108 on PAF-induced bronchoconstriction and intrathoracic accumulation of platelets in the guinea-pig
|
Heuer, H. |
|
1988 |
35 |
5 |
p. 798- 1 p. |
artikel |
6 |
Aggregation of platelets in vivo and bronchial hyperreactivity in response to PAF allows distinction between PAF-receptor antagonists and prophylactic anti-asthma drugs
|
Morley, J. |
|
1988 |
35 |
5 |
p. 820- 1 p. |
artikel |
7 |
Anesthesia prevents PAF-acether-induced leukocytosis in rats, but hemoconcentration is maintained
|
Martins, P.M.R.e S. |
|
1988 |
35 |
5 |
p. 835- 1 p. |
artikel |
8 |
Anti-inflammatory effects of BN-52021
|
Lorenzetti, B.B. |
|
1988 |
35 |
5 |
p. 835- 1 p. |
artikel |
9 |
A platelet activating factor antagonist inhibits the cerebral blood flow and neurochemical changes caused by cerebral injury-reperfusion
|
Bazan, N.G. |
|
1988 |
35 |
5 |
p. 831- 1 p. |
artikel |
10 |
Arachidonic acid metabolites do not mediate toluene diisocyanate-induced airway hyperresponsiveness in Guinea pigs
|
Gordon, Terry |
|
1988 |
35 |
5 |
p. 699-706 8 p. |
artikel |
11 |
5-aryl-2 3-dihydroimidazo [2,1-a] isoquinolines. A novel class of platelet-activating factor (PAF) receptor antagonists structurally derived from the PAF molecule
|
Houlihan, W.J. |
|
1988 |
35 |
5 |
p. 848- 1 p. |
artikel |
12 |
Benzodiazepine protection against PAF-acether toxicity in mice
|
Zeller, M. |
|
1988 |
35 |
5 |
p. 823- 1 p. |
artikel |
13 |
Biochemical and functional evidence for the existence of PAF receptors on human polymorphonuclear leukocytes
|
Marquis, O. |
|
1988 |
35 |
5 |
p. 795- 1 p. |
artikel |
14 |
Biological characterization of the enantiomeric hetrazepines of the paf-antagonist web 2170
|
Heuer, H. |
|
1988 |
35 |
5 |
p. 847- 1 p. |
artikel |
15 |
BN 52021 and specific binding sites for platelet activating factor (PAF) in brain and eyes
|
Domingo, M.T. |
|
1988 |
35 |
5 |
p. 815- 1 p. |
artikel |
16 |
BN 52021, inhibition of free polyunsaturated fatty acid accumulation in mouse brain during electroconvulsive shock and ischemia
|
Birkle, D.L. |
|
1988 |
35 |
5 |
p. 816- 1 p. |
artikel |
17 |
BN 52021 inhibits glomerular and mesangial cell contraction induced by cyclosporin A (CSA)
|
Rodriguez-Puyol, D. |
|
1988 |
35 |
5 |
p. 810- 1 p. |
artikel |
18 |
BN 52021 pretreatment protects against glycerol induced acute renal failure
|
Lopez-Novoa, JM |
|
1988 |
35 |
5 |
p. 811- 1 p. |
artikel |
19 |
Cardiovascular profile of 59227 RP, a novel potent and specific PAF receptor antagonists
|
Mondot, S. |
|
1988 |
35 |
5 |
p. 827- 1 p. |
artikel |
20 |
Cationic lipid PAF antagonists. Examination of a strategy to improve oral activity
|
Tomesch, J. |
|
1988 |
35 |
5 |
p. 844- 1 p. |
artikel |
21 |
Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats
|
Kochabek, P.M. |
|
1988 |
35 |
5 |
p. 830- 1 p. |
artikel |
22 |
Comparison of systemic and local eosinophil recruitment induced by PAF or immune challenge in the rat: Modulation by drugs
|
Etienne, A. |
|
1988 |
35 |
5 |
p. 804- 1 p. |
artikel |
23 |
Cytotoxic activity of non-charged platelet-activating factor (PAF) antagonists against murine tumor cell lines
|
Houlihan, W.J. |
|
1988 |
35 |
5 |
p. 817- 1 p. |
artikel |
24 |
Drug modulation of human neutrophil activation by PAF-acether
|
Rubino, A. |
|
1988 |
35 |
5 |
p. 796- 1 p. |
artikel |
25 |
Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and tumor necrosis factor induced changes in mortality and intestinal transit velocity
|
Heuer, H. |
|
1988 |
35 |
5 |
p. 814- 1 p. |
artikel |
26 |
Effect of a PAF analog on phospholipase activity and PAF responses
|
Kohler, C. |
|
1988 |
35 |
5 |
p. 843- 1 p. |
artikel |
27 |
Effect of intravenous or inhalative web 2086 on ex vivo platelet activating factor induced platelet aggregation in man
|
Adamus, W.S. |
|
1988 |
35 |
5 |
p. 797- 1 p. |
artikel |
28 |
Effect of PAF-acether and endotoxin on rat mesenteric microvessels; inhibition by specific antagonists
|
Lagente, V. |
|
1988 |
35 |
5 |
p. 808- 1 p. |
artikel |
29 |
Effect of PAF and PAF antagonists on hypothalamic neuropeptides release
|
Rougeot, C. |
|
1988 |
35 |
5 |
p. 816- 1 p. |
artikel |
30 |
Effect of PAF antagonists and cyclosporine on interstitium in infiltrating cells in experimental nephrosis
|
Egido, J. |
|
1988 |
35 |
5 |
p. 810- 1 p. |
artikel |
31 |
Effect of peroral web 2086 on ex vivo platelet activating factor induced platelet aggregation in man
|
Adamus, W.S. |
|
1988 |
35 |
5 |
p. 836- 1 p. |
artikel |
32 |
Effect of platelet-activating factor (PAF) on monocyte activation and production of tumor necrosis factor (TNF)
|
Bonavida, B. |
|
1988 |
35 |
5 |
p. 802- 1 p. |
artikel |
33 |
Effect of three chinese herbal medicines(ligustrazine, chrysanthemum indicum, salviae miltiorrhizae) on PAF and ADP-induced platelet aggregation in vitro
|
Levy, J.V. |
|
1988 |
35 |
5 |
p. 842- 1 p. |
artikel |
34 |
Effects of a PAF-antagonists and a cortcosteroid on cardiac transplant and native atherosclerosis in rabbits
|
Foegh, M. |
|
1988 |
35 |
5 |
p. 805- 1 p. |
artikel |
35 |
Effects of new chemically and metabolically stable prostacyclin analogues (iloprost and ZK 96480) on early consequences of a transient cerebral oligemia, in the rat
|
M.G., Borzeix |
|
1988 |
35 |
5 |
p. 653-664 12 p. |
artikel |
36 |
Effects of PAF antagonists on platelet behaviour and arrhythmias during myocardial ischaemia
|
Wainwright, C.L. |
|
1988 |
35 |
5 |
p. 809- 1 p. |
artikel |
37 |
Effects of PAF antagonists on renal vascular escape and tachyphylaxis in the isolated prefused rabbit kidney
|
Fonteles, M.C. |
|
1988 |
35 |
5 |
p. 827- 1 p. |
artikel |
38 |
Hemostasis changes induced by soluble aggregates of immunoglobulin G (IgG) in the rat. Studies with the PAF antagonist BN 52021
|
Fernandez-Gallardo, S. |
|
1988 |
35 |
5 |
p. 805- 1 p. |
artikel |
39 |
Histological and radiological assessment of neutrophil and platelet responses to PAF in vivo
|
Walker, J.R. |
|
1988 |
35 |
5 |
p. 841- 1 p. |
artikel |
40 |
Immune complex induced pancreatitis: Effect of BN 52021, a selective antagonist of platelet-activating factor
|
Jancar, Sonia |
|
1988 |
35 |
5 |
p. 757-770 14 p. |
artikel |
41 |
Inflammatory activity of a crude extract of coelenterate tentacles (Dactilometra) and the possible PAF-acether involvement
|
Cordeiro, R.S.B. |
|
1988 |
35 |
5 |
p. 836- 1 p. |
artikel |
42 |
Influence of anaesthetics on PAF-acether-induced death in mice
|
Subissi, A. |
|
1988 |
35 |
5 |
p. 834- 1 p. |
artikel |
43 |
Influence of BN 52021 on the cardio- and hemodynamic changes during deveplopment of the postischemic shock reaction
|
Sagach, V.F. |
|
1988 |
35 |
5 |
p. 812- 1 p. |
artikel |
44 |
Inhibition of arachidonic acid(AA)-induced contraction of guinea pig airways in vitro and in vivo by various inhibitors of phospholipid mediator synthesis
|
Slapke, J. |
|
1988 |
35 |
5 |
p. 821- 1 p. |
artikel |
45 |
Inhibition of gastric motility changes following PAF-acether and endotoxin by L-652, 731
|
Esplugues, J.V. |
|
1988 |
35 |
5 |
p. 829- 1 p. |
artikel |
46 |
Inhibition of PAF-induced effects in the guinea pig right atrium by BN 52021 and somatostatin
|
Hellegouarch, A. |
|
1988 |
35 |
5 |
p. 826- 1 p. |
artikel |
47 |
Inhibition of PAF-induced vascular permeability in rats, by the PAF-antagonist WEB 2086 and WEB 2170
|
Muacevic, G. |
|
1988 |
35 |
5 |
p. 839- 1 p. |
artikel |
48 |
Inhibition of the binding and aggregation to PAF in vitro in comparison with PAF-antagonism in vivo: An investigation using different types of PAF-antagonists
|
Heuer, H. |
|
1988 |
35 |
5 |
p. 838- 1 p. |
artikel |
49 |
Inhibitory action of WEB-2086 (a thieno-triazolodiazepine) and its cyclohexyl analog (WEB-2118) on platelet activating factor(PAF) induced aggregation of human platelets in whole blood
|
Levy, J.V. |
|
1988 |
35 |
5 |
p. 841- 1 p. |
artikel |
50 |
Interaction between PAF-acether and thromboxane in endotoxin-induced intestinal damage
|
Whittle, B.J.R. |
|
1988 |
35 |
5 |
p. 813- 1 p. |
artikel |
51 |
Interaction of fenoterol and web 2086 with propranolol morality in mice and broncho-constriction in the guinea pig to PAF-acether
|
Huber, H. |
|
1988 |
35 |
5 |
p. 850- 1 p. |
artikel |
52 |
Interactions between phospholipidic model membranes and two PAF antagonists, ginkgolides BN 52021 and BN 52024: An ESR-spin labelling study
|
Vachon, A. |
|
1988 |
35 |
5 |
p. 849- 1 p. |
artikel |
53 |
Interactions of hetrazepines with the central benzodiazepine receptor and the PAF receptor
|
Weber, K.H. |
|
1988 |
35 |
5 |
p. 847- 1 p. |
artikel |
54 |
Interference of ginkgolides with the rise in intraocular pressure after laser irradiation of the iris in the rabbit eye
|
Verbey, N.L.J. |
|
1988 |
35 |
5 |
p. 832- 1 p. |
artikel |
55 |
Interference of PAF-acether antagonists with the hyperresponsiveness to PAF-acether of lungs from actively sensitized guinea-pigs
|
Pretolani, M. |
|
1988 |
35 |
5 |
p. 800- 1 p. |
artikel |
56 |
Interference of the PAF-acether antagonist Ro 19–3704 with PAF-acether and FMLP-induced superoxide anion and thromboxane B2 generation by guinea-pig alveolar macrophages and rabbit neutrophils
|
Desquand, S. |
|
1988 |
35 |
5 |
p. 820- 1 p. |
artikel |
57 |
In vitro and in vivo effects of SM-10661, a newly synthesized platelet-activating factor (PAF) antagonist
|
Morooka, S. |
|
1988 |
35 |
5 |
p. 840- 1 p. |
artikel |
58 |
In vivo human platelet PAF receptor occupancy by WEB 2086: correlation with inhibition of platelet aggregation and WEB 2086 plasma levels
|
Birke, F.W. |
|
1988 |
35 |
5 |
p. 839- 1 p. |
artikel |
59 |
Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils
|
Spinnewyn, B. |
|
1988 |
35 |
5 |
p. 815- 1 p. |
artikel |
60 |
Involvement of platelet-activating factor (PAF) in corneal anterior segment inflammation
|
Bazan, H.E.P. |
|
1988 |
35 |
5 |
p. 832- 1 p. |
artikel |
61 |
iS Zn2+ a mediator of cellular responses?. A study in rat thymocytes
|
Senn, N. |
|
1988 |
35 |
5 |
p. 819- 1 p. |
artikel |
62 |
Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (rosaprostol)
|
Benfenati, E. |
|
1988 |
35 |
5 |
p. 665-684 20 p. |
artikel |
63 |
Mechanisms and pharmacological modulation of PAF-acether-induced death in mice
|
Criscuoli, M. |
|
1988 |
35 |
5 |
p. 822- 1 p. |
artikel |
64 |
Neutrophils induce platelet activation in rabbit and human: A role for PAF-acether only in rabbit
|
Coëffier, E. |
|
1988 |
35 |
5 |
p. 794- 1 p. |
artikel |
65 |
New strategies for the synthesis of sulfur substituted PAF analogues
|
Hajdu, J. |
|
1988 |
35 |
5 |
p. 848- 1 p. |
artikel |
66 |
Optimisation for a viable [3H]PAF binding to human platelet membranes
|
Tahraoui, L. |
|
1988 |
35 |
5 |
p. 794- 1 p. |
artikel |
67 |
Oxytocin stimulates the release of arachidonic acid and prostaglandin F2α from human decidual cells
|
Wilson, T. |
|
1988 |
35 |
5 |
p. 771-780 10 p. |
artikel |
68 |
PAF-acether antagonists and LTC4 formation by human eosinophils
|
Bruijnzeel, P.L.B. |
|
1988 |
35 |
5 |
p. 843- 1 p. |
artikel |
69 |
PAF-acether autogenerated in the guinea-pig arterial wall may account for local thromboformation
|
Bourgain, R. |
|
1988 |
35 |
5 |
p. 809- 1 p. |
artikel |
70 |
PAF-acether chemotactic activity on neutrophils in bronchial asthma. Effects of specific PAF-acether antagonists
|
Rabier, M. |
|
1988 |
35 |
5 |
p. 795- 1 p. |
artikel |
71 |
PAF-acether enhances the production of tumor necrosis factor by human and rodent lymphocytes and macrophages
|
Rola-Pleszczynski, M. |
|
1988 |
35 |
5 |
p. 802- 1 p. |
artikel |
72 |
PAF-acether in the carrageenan-induced inflammatory reaction in mice
|
Henriques, M.G.M.O. |
|
1988 |
35 |
5 |
p. 840- 1 p. |
artikel |
73 |
PAF-acether-PGE2 interactions in guinea-pig tracheal preparations
|
Brunelleschi, S. |
|
1988 |
35 |
5 |
p. 849- 1 p. |
artikel |
74 |
PAF antagonism in renal ischemia
|
Plante, G.E. |
|
1988 |
35 |
5 |
p. 828- 1 p. |
artikel |
75 |
PAF-antagonists and thromboxane (TX) antagonists abolish PAF-induced cardiac rhythym disturbances
|
Mest, H.-J. |
|
1988 |
35 |
5 |
p. 807- 1 p. |
artikel |
76 |
PAF antagonists protect mice against lethality caused by active anphylactic shock
|
Sedivy, P. |
|
1988 |
35 |
5 |
p. 823- 1 p. |
artikel |
77 |
PAF antagonists SDZ 63–441 and SDZ 63–675. Synthesis of and pharmacological characterization of the individual enantiomers
|
Tomesch, J. |
|
1988 |
35 |
5 |
p. 845- 1 p. |
artikel |
78 |
PAF enhances erytrophagocytic activity of human monocytes by the protein kinase C dependent phosphorylation of C3b receptor (CR1). Role of PAF receptor antagonists
|
Bussolino, F. |
|
1988 |
35 |
5 |
p. 803- 1 p. |
artikel |
79 |
PAF increases vascular permeability in selected tissues: Effect of BN52021 and L-655,240
|
Sirois, P. |
|
1988 |
35 |
5 |
p. 798- 1 p. |
artikel |
80 |
PAF-induced airway hyperresponsiveness: Effect on contractility of guinea-pig trachea
|
Giorgetti, C. |
|
1988 |
35 |
5 |
p. 822- 1 p. |
artikel |
81 |
PAF-induced edema and bronchoconstriction in the perfused lung
|
Tozzi, S. |
|
1988 |
35 |
5 |
p. 799- 1 p. |
artikel |
82 |
PAF-induced platelet response is enhanced by polymorphonuclear leukocytes (PMN)
|
Del Maschio, A. |
|
1988 |
35 |
5 |
p. 818- 1 p. |
artikel |
83 |
PAF stimulates arachidonic acid metabolism in rat liver cells by a receptor-mediated mechanism
|
Levine, L. |
|
1988 |
35 |
5 |
p. 796- 1 p. |
artikel |
84 |
Pharmacological modulation of PAF-acether-induced pleuresy in rats and its relevance for inflammation by zymosan
|
R.S.B., Cordeiro |
|
1988 |
35 |
5 |
p. 801- 1 p. |
artikel |
85 |
Pharmacological profile of a novel potent and specific PAF receptor antagonist, the 59227 RP
|
Robaut, C. |
|
1988 |
35 |
5 |
p. 838- 1 p. |
artikel |
86 |
Pharmacological studies on dithranol-induced dermatitis
|
Kemeny, L. |
|
1988 |
35 |
5 |
p. 834- 1 p. |
artikel |
87 |
Platelet activating factor induced inflammatory responses in the skin
|
Sciberras, D.G. |
|
1988 |
35 |
5 |
p. 833- 1 p. |
artikel |
88 |
Platelet-activating factor (PAF) causes goblet cell depletion in addition to inflammatory effects on the conjunctiva
|
Woodward, D.F. |
|
1988 |
35 |
5 |
p. 833- 1 p. |
artikel |
89 |
Platelet activating factor (PAF) stimulates a phospholipase C (PLC) in differentiated human monocytic leukemia (U-937) cells, resulted in phosphoinositide (PI) hydrolysis and introcellular calcium ([Ca2+]i) mobilization
|
Barzaghi, Giovanna |
|
1988 |
35 |
5 |
p. 819- 1 p. |
artikel |
90 |
Platelet-activating factor receptor blockade decreases early post-traumatic cerebral edema in rats
|
Buchanan, D.C. |
|
1988 |
35 |
5 |
p. 814- 1 p. |
artikel |
91 |
Platelet aggregation in asthma
|
Palma-Carlos, A.G. |
|
1988 |
35 |
5 |
p. 801- 1 p. |
artikel |
92 |
Potentiation of the immunosuppressive action of cyclosporine a (CSA) by the platelet-activating factor (PAF) antagonist, BN 52063
|
B., Pignol |
|
1988 |
35 |
5 |
p. 824- 1 p. |
artikel |
93 |
Presence of specific platelet-activating factor (PAF) binding sites in the mammalian retina and their implication for visual function
|
Doly, M. |
|
1988 |
35 |
5 |
p. 830- 1 p. |
artikel |
94 |
Prolongation of experimental liver xenograft survival using a PAF antagonist
|
Filipponi, F. |
|
1988 |
35 |
5 |
p. 806- 1 p. |
artikel |
95 |
Protection by BN 52021, a PAF receptor antagonist of ischemia-induced arrhythmias in isolated working rat hearts
|
Tosaki, A. |
|
1988 |
35 |
5 |
p. 851- 1 p. |
artikel |
96 |
Protein kinase C and the PAF cycle in the cornea
|
Bazan, N.G. |
|
1988 |
35 |
5 |
p. 831- 1 p. |
artikel |
97 |
Rearrangement of 5S, 12S-dihydroxy-6,8,10,14-(E,Z,E,Z)-eicosatetraenoic acid during gas chromatography: formation of a cyclohexadiene derivative
|
Borgeat, Pierre |
|
1988 |
35 |
5 |
p. 723-731 9 p. |
artikel |
98 |
Renal microcirculation during plateler-activating factor (PAF) antagonist (BN) administration
|
Santos, OFP. |
|
1988 |
35 |
5 |
p. 828- 1 p. |
artikel |
99 |
Role of platelet-activating factor (PAF) in ovoimplantation and decidualization process in the rat
|
Acker, G.M. |
|
1988 |
35 |
5 |
p. 817- 1 p. |
artikel |
100 |
Specific leukotriene D4 receptors on guinea-pig alveolar macrophages
|
Cristol, J.P. |
|
1988 |
35 |
5 |
p. 747-756 10 p. |
artikel |
101 |
Structure-activity relationship of 2-o-ethyl-PAF analogues
|
Ostermann, G. |
|
1988 |
35 |
5 |
p. 844- 1 p. |
artikel |
102 |
Studies of the mechanism of candida albicans killing by human epidermal cells: A role for PAF
|
Csato, M. |
|
1988 |
35 |
5 |
p. 797- 1 p. |
artikel |
103 |
Studies on the mechanisms of the hemoconcentration produced by PAF and endotoxin in rats
|
Floch, A. |
|
1988 |
35 |
5 |
p. 808- 1 p. |
artikel |
104 |
Study of the effect of various drugs toward PAF-induced gastro-intestinal damage in the rat
|
Etienne, A. |
|
1988 |
35 |
5 |
p. 829- 1 p. |
artikel |
105 |
Sybergism between Bn 52021, a specific PAF receptor antagonist and somatostatin analogues in anaphylaxis and inflammation
|
Koltai, M. |
|
1988 |
35 |
5 |
p. 850- 1 p. |
artikel |
106 |
Synthesis and metabolism of PAF in activated human neutrophils: inhibitory effect of calcium channel blockers nifedipine and verapamil and pertussis toxin
|
Müller, S. |
|
1988 |
35 |
5 |
p. 842- 1 p. |
artikel |
107 |
Synthesis and structure-activity relationship of 2,5-diaryltetrahydrofurans as PAF antagonists
|
Biftu, T. |
|
1988 |
35 |
5 |
p. 846- 1 p. |
artikel |
108 |
Synthesis of new pyrrolo [1,2-c] thiazole derivatives as potent and specific PAF-antagonists
|
Lavé, D. |
|
1988 |
35 |
5 |
p. 846- 1 p. |
artikel |
109 |
Systematic effects of stable analogues of PAF in the rat
|
Hofmann, B. |
|
1988 |
35 |
5 |
p. 825- 1 p. |
artikel |
110 |
Tetrahydrofuran derivatives as PAF-acether antagonists - structure-activity relationship
|
Heymans, F. |
|
1988 |
35 |
5 |
p. 845- 1 p. |
artikel |
111 |
The contribution of platelets and PAF to allergen-induced late-onset responses and bronchial
|
Page, C.P. |
|
1988 |
35 |
5 |
p. 800- 1 p. |
artikel |
112 |
The effect of an orally active leukotriene (LT) D4 antagonist WY-48, 252 on LTD4 and antigen-induced bronchoconstructions in allergic sheep
|
Abraham, W.M. |
|
1988 |
35 |
5 |
p. 733-745 13 p. |
artikel |
113 |
The effect of PAF-acether antagonist (BN 52021) on cyclosporine (CsA) nephrotoxicity: glomerular hemodynamic evaluation
|
Santos, OFP. |
|
1988 |
35 |
5 |
p. 811- 1 p. |
artikel |
114 |
The effect of PAF antagonists on the hepatic glycogenolysis and diabetes induced by alloxan
|
Hernando, P. |
|
1988 |
35 |
5 |
p. 818- 1 p. |
artikel |
115 |
The effect of platelet activating factor and BN52021, a platelet activating antagonist, on the biology of lymphocytes
|
Gebhardt, B.M. |
|
1988 |
35 |
5 |
p. 824- 1 p. |
artikel |
116 |
The effect of platelet-activating factor (PAF) antagonists and somatostatin analogues on lymphocytes and natural killer (NK) cell cytotoxicity
|
Farkas, G. |
|
1988 |
35 |
5 |
p. 804- 1 p. |
artikel |
117 |
The effects of different platelet activating factor (PAF) antagonists on PAF induced hypotension in the pithed rat
|
English, J. |
|
1988 |
35 |
5 |
p. 825- 1 p. |
artikel |
118 |
The effects of specific PAF receptor antagonist BN 52021 on hypoxia-induced spasm of isolated coronary arteries
|
Soloviev, A.I. |
|
1988 |
35 |
5 |
p. 807- 1 p. |
artikel |
119 |
The ginkgolide BN-52021 prevents anaphylactic response in guinea-pig
|
Berti, F. |
|
1988 |
35 |
5 |
p. 821- 1 p. |
artikel |
120 |
There is a case for PAF-acether antagonists
|
|
|
1988 |
35 |
5 |
p. 781-793 13 p. |
artikel |
121 |
The role of a PAF-antagonist in experimental hyperacute rejection (HAR)
|
Makowka, L |
|
1988 |
35 |
5 |
p. 806- 1 p. |
artikel |
122 |
The role of platelet activating factor in endotoxemic acute renal failure in the rat
|
Tolins, JP |
|
1988 |
35 |
5 |
p. 812- 1 p. |
artikel |
123 |
The VII international conference on “prostaglandins and related compounds”
|
|
|
1988 |
35 |
5 |
p. 651- 1 p. |
artikel |
124 |
Thromboxane increases pulmonary vascular resistance and transvascular fluid and protein exchange after pulmonary microembolism
|
Garcia-Szabo, Rene |
|
1988 |
35 |
5 |
p. 707-721 15 p. |
artikel |
125 |
Tolerance study, pharmacokinetics and ex vivo PAF-induced platelet aggregation after repeated oral doses of 48740 RP in normal volunteers
|
Pinquier, J.L. |
|
1988 |
35 |
5 |
p. 837- 1 p. |
artikel |
126 |
Tumor necrosis factor (TNF) primes platelet activating factor (PAF)-induced superoxide generation by human neutrophils (PMN): Consequences in promoting PMN-mediated endothelial cell (EC) damages
|
Paubert-Braquet, Monique |
|
1988 |
35 |
5 |
p. 803- 1 p. |
artikel |
127 |
Use of PAF antagonists to assess the role of PAF in allergen-induced responses of the guinea-pig airway
|
Boubekeur, K. |
|
1988 |
35 |
5 |
p. 799- 1 p. |
artikel |
128 |
1989 Winter prostaglandin conference
|
|
|
1988 |
35 |
5 |
p. 652- 1 p. |
artikel |